| Vernon Health & Rehabilitation | |
| 1955 S Vernon St, Wabash, Indiana 46992 | |
| (260) 563-8438 | |
| Name | Vernon Health & Rehabilitation |
|---|---|
| Location | 1955 S Vernon St, Wabash, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 119 |
| Occupancy Rate | 47.14% |
| Medicare ID (CCN) | 155810 |
| Legal Business Name | Putnam County Hospital |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1316932874 |
| Organization Name | PUTNAM COUNTY HOSPITAL |
| Doing Business As | VERNON MANOR CHILDRENS HOME |
| Address | 1955 Vernon St, Wabash, IN 46992 |
| Phone Number | 260-563-8438 |
News Archive
Latham & Watkins, a leading global law firm, is working with its lawyers and staff to promote healthy lifestyle choices and encourage workplace wellness. The CEO Roundtable on CancerTM has accredited Latham & Watkins with the CEO Cancer Gold Standard recognizing the firm's efforts to reduce the risk of cancer for its employees and covered family members by establishing programs to reduce cancer risk, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
The brain's effect on other parts of the body has been well established. Now, a group that includes two University of Florida Health researchers has found that it's a two-way street: Body fat can send a signal that affects the way the brain deals with stress and metabolism.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today issued the following statement in response to two recent lawsuits filed in the name of CytRx shareholders:
In response to the challenges hospitals face to move and store multiple Terabytes of radiology images, Allied Telesis, a global leader in IP/Ethernet networking solutions for enterprise, network service provider, and government institutions, announces a full slate of demonstrations and activities highlighting the performance benefits achieved using high-capacity networking and cloud-based storage at the annual RSNA meeting in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and uptake of Human Genome Sciences/GlaxoSmithKline's Benlysta, the systemic lupus erythematosus (SLE) drug market will quadruple from about $400 million in 2009 to more than $1.6 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Latham & Watkins, a leading global law firm, is working with its lawyers and staff to promote healthy lifestyle choices and encourage workplace wellness. The CEO Roundtable on CancerTM has accredited Latham & Watkins with the CEO Cancer Gold Standard recognizing the firm's efforts to reduce the risk of cancer for its employees and covered family members by establishing programs to reduce cancer risk, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
The brain's effect on other parts of the body has been well established. Now, a group that includes two University of Florida Health researchers has found that it's a two-way street: Body fat can send a signal that affects the way the brain deals with stress and metabolism.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today issued the following statement in response to two recent lawsuits filed in the name of CytRx shareholders:
In response to the challenges hospitals face to move and store multiple Terabytes of radiology images, Allied Telesis, a global leader in IP/Ethernet networking solutions for enterprise, network service provider, and government institutions, announces a full slate of demonstrations and activities highlighting the performance benefits achieved using high-capacity networking and cloud-based storage at the annual RSNA meeting in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and uptake of Human Genome Sciences/GlaxoSmithKline's Benlysta, the systemic lupus erythematosus (SLE) drug market will quadruple from about $400 million in 2009 to more than $1.6 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $147461 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.14 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.23 | 5.51 |